Thomas Hope, MD
Professor
Radiology
School of Medicine

In 2007, he received his medical degree from Stanford University School of Medicine and he completed a one-year internship at Kaiser Permanente, San Francisco. From 2008-2012, Dr. Hope completed a residency in Diagnostic Radiology at the University of California, San Francisco, followed by a clinical fellowship in Body MRI and Nuclear Medicine from Stanford Medical Center in 2013.

Dr. Hope’s main research focus is on novel imaging agents and therapies, particularly in prostate cancer and neuroendocrine tumors. He lead the development of Ga-68 PSMA-11, which subsequently led to the approval of this drug by the FDA. He has combined his interest in MR imaging with PET in the simultaneous modality PET/MRI, helping lead the development of the clinical PET/MRI program. Additionally he leads the PRRT (peptide receptor radionuclide therapy) program for neuroendocrine tumors and PSMA Radioligand Therapy at UCSF.

An international leader in PET/MR research and the translation of new molecular imaging agents, Dr. Hope launched the highly successful PSMA prostate program at UCSF and championed the use of multiple new targeted therapies to treat patients with neuroendocrine and other tumors. He current serves as principal investigator on grants from the NIH, the Prostate Cancer Foundation. He is the recipient of numerous accolades in molecular imaging, including the Henkin Fellow and Marc Tetalman Memorial Award from the Society of Nuclear Medicine and Molecular Imaging, the Young Investigator Award from the Prostate Cancer Foundation and the Wylie J. Dodds Research Award from the Society of Abdominal Radiology.

Expertise: Abdominal Imaging and Nuclear Medicine, and Molecular Imaging and Therapeutics

Professional Interests: Novel imaging agents, PET/MR, prostate cancer, neuroendocrine tumor, radioligand therapy

Education and Training:

• Medical School: Stanford University School of Medicine, California
• Internship: Kaiser Permanente, San Francisco, California
• Residency: University of California, San Francisco - Diagnostic Radiology
• Fellowship: Stanford Medical Center, California - Body MRI and Nuclear Medicine
• California Medical License
• American Board of Radiology, Certificate in Diagnostic Radiology
• American Board of Nuclear Medicine, Certificate in Nuclear Medicine

• Technical note: Errors introduced when using Dose Voxel Kernels for estimating absorbed dose from radiopharmaceutical therapies involving alpha emitters.
  Medical physics 2024 Tranel J, Palm S, Feng FY, St James S, Hope TA
• Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2024 Koshkin VS, Kumar V, Kline B, Escobar D, Aslam M, Cooperberg MR, Aggarwal RR, de Kouchkovsky I, Chou J, Meng MV, Friedlander T, Porten S, Hope TA
• Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774).
  European urology 2024 Armstrong WR, Kishan AU, Booker KM, Grogan TR, Elashoff D, Lam EC, Clark KJ, Steinberg ML, Fendler WP, Hope TA, Nickols NG, Czernin J, Calais J
• PSMA PET AUC Updates: Inclusion of rh-PSMA-7.3.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2024 Hope TA, Jadvar H
• Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2024 Emmett L, Papa N, Counter W, Calais J, Barbato F, Burger I, Eiber M, Roberts MJ, Agrawal S, Franklin A, Xue A, Rasiah K, John N, Moon D, Frydenberg M, Yaxley J, Stricker P, Wong K, Coughlin G, …
• Correction to: PET/MRI in colorectal and anal cancers: an update.
  Abdominal radiology (New York) 2023 Jayaprakasam VS, Ince S, Suman G, Nepal P, Hope TA, Paspulati RM, Fraum TJ
• Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial.
  The Lancet. Oncology 2023 Aggarwal R, Starzinski S, de Kouchkovsky I, Koshkin V, Bose R, Chou J, Desai A, Kwon D, Kaushal S, Trihy L, Rastogi M, Ippisch R, Aslam M, Friedlander T, Feng F, Oh D, Cheung A, Small E, Evans M, Fong…
• Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.
  Journal of the National Cancer Institute 2023 Singh S, Hope TA, Bergsland EB, Bodei L, Bushnell DL, Chan JA, Chasen BR, Chauhan A, Das S, Dasari A, Del Rivero J, El-Haddad G, Goodman KA, Halperin DM, Lewis MA, Lindwasser OW, Myrehaug S, Raj NP, …
• International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.
  European journal of nuclear medicine and molecular imaging 2023 Veit-Haibach P, Ahlström H, Boellaard R, Delgado Bolton RC, Hesse S, Hope T, Huellner MW, Iagaru A, Johnson GB, Kjaer A, Law I, Metser U, Quick HH, Sattler B, Umutlu L, Zaharchuk G, Herrmann K
• Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2023 Hope TA, Benz M, Jiang F, Thompson D, Barbato F, Juarez R, Hernandez Pampaloni M, Allen-Auerbach M, Gupta P, Fendler WP, Calais J
• Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial.
  European urology 2023 Djaïleb L, Armstrong WR, Thompson D, Gafita A, Farolfi A, Rajagopal A, Grogan TR, Nguyen K, Benz MR, Hotta M, Barbato F, Ceci F, Schwarzenböck SM, Unterrainer M, Zacho HD, Juarez R, Cooperberg M, …
• Prostate-specific Membrane Antigen Reporting and Data System Version 2.0.
  European urology 2023 Werner RA, Hartrampf PE, Fendler WP, Serfling SE, Derlin T, Higuchi T, Pienta KJ, Gafita A, Hope TA, Pomper MG, Eiber M, Gorin MA, Rowe SP
• SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2023 Hope TA, Antonarakis ES, Bodei L, Calais J, Iravani A, Jacene H, Koo PJ, Morgans AK, Osborne JR, Tagawa ST, Taplin ME, Sartor O, Morris MJ
• Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
  European journal of nuclear medicine and molecular imaging 2023 Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L, Baum RP, Bozkurt MF, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal…
• 68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2023 Mei R, Kessler L, Pabst KM, Weber M, Schmidkonz C, Rischpler C, Zacho HD, Hope T, Schwarzenböck SM, Allen-Auerbach M, Emmett L, Ferdinandus J, Unterrainer M, Schaarschmidt BM, Umutlu L, Farolfi A, …
• Editorial Comment.
  The Journal of urology 2023 Eifer M, Hope TA, Calais J, Hofman MS
• Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas.
  British journal of cancer 2023 Raj N, Chan JA, Wang SJ, Aggarwal RR, Calabrese S, DeMore A, Fong L, Grabowsky J, Hope TA, Kolli KP, Mulvey CK, Munster PN, Perez K, Punn S, Reidy-Lagunes D, Von Fedak S, Zhang L, Bergsland EK
• Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel.
  Abdominal radiology (New York) 2023 Lee S, Kassam Z, Baheti AD, Hope TA, Chang KJ, Korngold EK, Taggart MW, Horvat N
• PET/MRI in colorectal and anal cancers: an update.
  Abdominal radiology (New York) 2023 Jayaprakasam VS, Ince S, Suman G, Nepal P, Hope TA, Paspulati RM, Fraum TJ
• Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time.
  Journal of neuroendocrinology 2023 Wang SJ, Whitman J, Paciorek A, Le BK, Nakakura EK, Behr SC, Joseph N, Zhang L, Hope TA, Bergsland EK
• PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2023 Hotta M, Gafita A, Murthy V, Benz MR, Sonni I, Burger IA, Eiber M, Emmett L, Farolfi A, Fendler WP, Weber MM, Hofman MS, Hope TA, Kratochwil C, Czernin J, Calais J
• Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology.
  Abdominal radiology (New York) 2023 Golia Pernicka JS, Rauch GM, Gangai N, Bates DDB, Ernst R, Hope TA, Horvat N, Sheedy SP, Gollub MJ
• Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2).
  European urology 2023 Seifert R, Emmett L, Rowe SP, Herrmann K, Hadaschik B, Calais J, Giesel FL, Reiter R, Maurer T, Heck M, Gafita A, Morris MJ, Fanti S, Weber WA, Hope TA, Hofman MS, Fendler WP, Eiber M
• Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios.
  Abdominal radiology (New York) 2023 Konstantinoff KS, Morani AC, Hope TA, Bhosale PR, Francis IR, Yano M, Iravani A, Trikalinos NA, Itani M
• SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2023 Hope TA, Allen-Auerbach M, Bodei L, Calais J, Dahlbom M, Dunnwald LK, Graham MM, Jacene HA, Heath CL, Mittra ES, Wright CL, Fendler WP, Herrmann K, Taïeb D, Kjaer A
• Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Q and A.
  JCO oncology practice 2023 Garje R, Hope TA, Rumble RB, Parikh RA, Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
• PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
  European journal of nuclear medicine and molecular imaging 2023 Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, Cho SY, Fanti S, Giesel FL, Goffin K, Haberkorn U, Jacene H, Koo PJ, Kopka K, Krause BJ, Lindenberg L, Marcus C, Mottaghy FM, Oprea-Lager …
• Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET.
  Cancers 2022 Sabbagh A, Mohamad O, Lichter KE, Hope TA
• Using PSMA imaging for prognostication in localized and advanced prostate cancer.
  Nature reviews. Urology 2022 Roberts MJ, Maurer T, Perera M, Eiber M, Hope TA, Ost P, Siva S, Hofman MS, Murphy DG, Emmett L, Fendler WP
• Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers.
  Urologic oncology 2022 Kwon DH, Shakhnazaryan N, Shui D, Hong JC, Mohamad O, de Kouchkovsky I, Borno HT, Bose R, Chou J, Desai A, Fong L, Friedlander TW, Koshkin VS, Aggarwal RR, Feng FY, Hope TA, Small EJ
• Synthetic PET via Domain Translation of 3-D MRI.
  IEEE transactions on radiation and plasma medical sciences 2022 Rajagopal A, Natsuaki Y, Wangerin K, Hamdi M, An H, Sunderland JJ, Laforest R, Kinahan PE, Larson PEZ, Hope TA
• Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model.
  EJNMMI physics 2022 Tranel J, Palm S, Graves SA, Feng FY, Hope TA
• Imaging joint infections using D-methyl-11C-methionine PET/MRI: initial experience in humans.
  European journal of nuclear medicine and molecular imaging 2022 Polvoy I, Seo Y, Parker M, Stewart M, Siddiqua K, Manacsa HS, Ravanfar V, Blecha J, Hope TA, Vanbrocklin H, Flavell RR, Barry J, Hansen E, Villanueva-Meyer JE, Engel J, Rosenberg OS, Wilson DM, …
• ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.
  Clinical nuclear medicine 2022 Love C, Desai NB, Abraham T, Banks KP, Bodei L, Boike T, Brown RKJ, Bushnell DL, DeBlanche LE, Dominello MM, Francis T, Grady EC, Hobbs RF, Hope TA, Kempf JS, Pryma DA, Rule W, Savir-Baruch B, Sethi I…
• Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time?
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Hope TA, Pavel M, Bergsland EK
• Choice Is Good at Times: The Emergence of [64Cu]Cu-DOTATATE-Based Somatostatin Receptor Imaging in the Era of [68Ga]Ga-DOTATATE.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2022 Jha A, Patel M, Carrasquillo JA, Chen CC, Millo C, Maass-Moreno R, Ling A, Lin FI, Lechan RM, Hope TA, Taïeb D, Civelek AC, Pacak K
• ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.
  American journal of clinical oncology 2022 Love C, Desai NB, Abraham T, Banks KP, Bodei L, Boike T, Brown RKJ, Bushnell DL, DeBlanche LE, Dominello MM, Francis T, Grady EC, Hobbs RF, Hope TA, Kempf JS, Pryma DA, Rule W, Savir-Baruch B, Sethi I…
• Updates to Appropriate Use Criteria for PSMA PET.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2022 Hope TA, Jadvar H
• Best Approaches and Updates for Prostate Cancer Biochemical Recurrence.
  American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2022 Simon NI, Parker C, Hope TA, Paller CJ
• Leadership in Patient Advocacy: A Conversation Between Josh Mailman and Thomas Hope.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2022 Mailman J, Hope TA
• PSMA PET in Prostate Cancer-A Biomarker or a Surrogate End Point?-Reply.
  JAMA oncology 2022 Hope TA, Calais J
• Impact of Implicit Abdominal Aortic Aneurysm Screening in the Veterans Affairs Health Care System Over 10 Years.
  Journal of the American Heart Association 2022 Leach JR, Shen H, Huo E, Hope TA, Mitsouras D, Whooley MA, Hope MD
• The PRIMARY Score: Using Intraprostatic 68Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2022 Emmett L, Papa N, Buteau J, Ho B, Liu V, Roberts M, Thompson J, Moon D, Sheehan-Dare G, Alghazo O, Agrawal S, Murphy D, Stricker P, Hope TA, Hofman MS
• Reply: Single-Time-Point Tumor Dosimetry Assuming Normal Distribution of Tumor Kinetics.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2022 Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB
• Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose.
  The Lancet. Oncology 2022 Lawhn-Heath C, Hope TA, Martinez J, Fung EK, Shin J, Seo Y, Flavell RR
• Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Schöder H, Hope TA, Knopp M, Kelly WK, Michalski JM, Lerner SP, Tawab-Amiri A, Mann BS, Lin DW, Yu EY, Chen RC, Beach GC, Reeves SA, Members of the Working Group, Shankar LK
• Discovery and characterization of circulating tumor cell clusters in neuroendocrine tumor patients using nanosubstrate-embedded microchips.
  Biosensors & bioelectronics 2021 Sun N, Yang Y, Miao H, Redublo P, Liu H, Liu W, Huang YW, Teng PC, Zhang C, Zhang RY, Smalley M, Yang P, Chou SJ, Huai K, Zhang Z, Lee YT, Wang JJ, Wang J, Liang IY, Zhang TX, Zhang D, Liang L, Weiss …
• Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Pandit-Taskar N, Iravani A, Lee D, Jacene H, Pryma D, Hope T, Saboury B, Capala J, Wahl RL
• Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB
• Response to "Preoperative localization in primary hyperparathyroidism: Views from the developing world".
  Surgery 2021 Graves CE, Hope TA, Suh I
• Harmonization of PET image reconstruction parameters in simultaneous PET/MRI.
  EJNMMI physics 2021 Laforest R, Khalighi M, Natsuaki Y, Rajagopal A, Chandramohan D, Byrd D, An H, Larson P, James SS, Sunderland JJ, Kinahan PE, Hope TA
• Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.
  JAMA oncology 2021 Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, Behr SC, Zhang L, Barbato F, Ceci F, Farolfi A, Schwarzenböck SM, Unterrainer M, Zacho HD, Nguyen HG, Cooperberg MR, Carroll PR, …
• Preoperative risk stratification of lymph node metastasis for non-functional pancreatic neuroendocrine neoplasm: An international dual-institutional study.
  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2021 Kasai Y, Masui T, Nakakura EK, Nakano K, Sato A, Uchida Y, Yogo A, Nagai K, Anazawa T, Hope TA, Kim GE, Whitman J, Le BK, Takaori K, Bergsland EK, Hatano E, Uemoto S
• PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Ferdinandus J, Fendler WP, Farolfi A, Washington S, Mohamad O, Pampaloni MH, Scott PJH, Rodnick M, Viglianti BL, Eiber M, Herrmann K, Czernin J, Armstrong WR, Calais J, Hope TA, Piert M
• Attenuation Coefficient Estimation for PET/MRI With Bayesian Deep Learning Pseudo-CT and Maximum-Likelihood Estimation of Activity and Attenuation.
  IEEE transactions on radiation and plasma medical sciences 2021 Leynes AP, Ahn S, Wangerin KA, Kaushik SS, Wiesinger F, Hope TA, Larson PEZ
• Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Jadvar H, Calais J, Fanti S, Feng F, Greene KL, Gulley JL, Hofman M, Koontz BF, Lin DW, Morris MJ, Rowe SP, Royce TJ, Salami S, Savir-Baruch B, Srinivas S, Hope TA
• Evaluation of attenuation correction in PET/MRI with synthetic lesion insertion.
  Journal of medical imaging (Bellingham, Wash.) 2021 Hamdi M, Natsuaki Y, Wangerin KA, An H, St James S, Kinahan PE, Sunderland JJ, Larson PEZ, Hope TA, Laforest R
• RESIST-PC: U.S. Academic Foray into PSMA Theranostic Trials.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Iravani A, Hope TA
• A cost-utility analysis of 18F-fluorocholine-positron emission tomography imaging for localizing primary hyperparathyroidism in the United States.
  Surgery 2021 Yap A, Hope TA, Graves CE, Kluijfhout W, Shen WT, Gosnell JE, Sosa JA, Roman SA, Duh QY, Suh I
• A Comprehensive Assessment of 68Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Abghari-Gerst M, Armstrong WR, Nguyen K, Calais J, Czernin J, Lin D, Jariwala N, Rodnick M, Hope TA, Hearn J, Montgomery JS, Alva A, Reichert ZR, Spratt DE, Johnson TD, Scott PJH, Piert M
• A Path to Qualification of PET/MRI Scanners for Multicenter Brain Imaging Studies: Evaluation of MRI-Based Attenuation Correction Methods Using a Patient Phantom.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Catana C, Laforest R, An H, Boada F, Cao T, Faul D, Jakoby B, Jansen FP, Kemp BJ, Kinahan PE, Larson P, Levine MA, Maniawski P, Mawlawi O, McConathy JE, McMillan AB, Price JC, Rajagopal A, Sunderland …
• Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Park S, Parihar AS, Bodei L, Hope TA, Mallak N, Millo C, Prasad K, Wilson D, Zukotynski K, Mittra E
• Superior sensitivity of 18F-fluorocholine: PET localization in primary hyperparathyroidism.
  Surgery 2021 Graves CE, Hope TA, Kim J, Pampaloni MH, Kluijfhout W, Seib CD, Gosnell JE, Shen WT, Roman SA, Sosa JA, Duh QY, Suh I
• Perspectives on Radiopharmaceutical Agents from the FDA: A Conversation between Lou Marzella, Johannes Czernin, and Thomas Hope.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Marzella L, Czernin J, Hope T
• Prostate-specific membrane antigen (PSMA)-based imaging in localized and advanced prostate cancer: a narrative review.
  Translational andrology and urology 2021 de Kouchkovsky I, Aggarwal R, Hope TA
• A bicentric retrospective analysis of clinical utility of 18F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria?
  European journal of nuclear medicine and molecular imaging 2021 Salavati A, Gencturk M, Koksel Y, Schik AN, Carroll PR, Feng FY, Rowe SP, Lawhn-Heath C, Hope TA, Froelich JW
• Pitfalls on PET/MRI.
  Seminars in nuclear medicine 2021 Afaq A, Faul D, Chebrolu VV, Wan S, Hope TA, Haibach PV, Bomanji J
• Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer.
  European urology 2021 Chu CE, Alshalalfa M, Sjöström M, Zhao SG, Liu Y, Chou J, Herlemann A, Mahal B, Kishan AU, Spratt DE, Cooperberg M, Small E, Wong A, Porten S, Hope TA, Ross AE, Davicioni E, Nguyen P, Karnes RJ, …
• More Answers and More Questions About Radiotherapy for Metastatic Prostate Cancer.
  JAMA oncology 2021 Koontz BF, Hope TA
• The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.
  Pancreas 2021 Fishbein L, Del Rivero J, Else T, Howe JR, Asa SL, Cohen DL, Dahia PLM, Fraker DL, Goodman KA, Hope TA, Kunz PL, Perez K, Perrier ND, Pryma DA, Ryder M, Sasson AR, Soulen MC, Jimenez C
• Prostate-specific Membrane Antigen PET in Prostate Cancer.
  Radiology 2021 Lawhn-Heath C, Salavati A, Behr SC, Rowe SP, Calais J, Fendler WP, Eiber M, Emmett L, Hofman MS, Hope TA
• Reply: Disparities in PET Imaging of Prostate Cancer at a Tertiary Academic Medical Center.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Bucknor MD, Hope TA
• High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Jha A, Taïeb D, Carrasquillo JA, Pryma DA, Patel M, Millo C, de Herder WW, Del Rivero J, Crona J, Shulkin BL, Virgolini I, Chen AP, Mittal BR, Basu S, Dillon JS, Hope TA, Mari Aparici C, Iagaru AH, …
• Accuracy of 18F-Fluorocholine PET for the Detection of Parathyroid Adenomas: Prospective Single-Center Study.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Hope TA, Graves CE, Calais J, Ehman EC, Johnson GB, Thompson D, Aslam M, Duh QY, Gosnell JE, Shen WT, Roman SA, Sosa JA, Kluijfhout WP, Seib CD, Villaneuva-Meyer JE, Pampaloni MH, Suh I
• E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET.
  European journal of nuclear medicine and molecular imaging 2021 Ceci F, Oprea-Lager DE, Emmett L, Adam JA, Bomanji J, Czernin J, Eiber M, Haberkorn U, Hofman MS, Hope TA, Kumar R, Rowe SP, Schwarzenboeck SM, Fanti S, Herrmann K
• PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer.
  Lancet (London, England) 2021 Hope TA, Calais J
• The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer.
  European urology focus 2021 Murthy V, Sonni I, Jariwala N, Juarez R, Reiter RE, Raman SS, Hope TA
• Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Sartor O, Hope TA, Calais J, Fendler WP
• Effect of microdistribution of alpha and beta-emitters in targeted radionuclide therapies on delivered absorbed dose in a GATE model of bone marrow.
  Physics in medicine and biology 2021 Tranel J, Feng FY, James SS, Hope TA
• Assessment and Comparison of 18F-Fluorocholine PET and 99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021 Whitman J, Allen IE, Bergsland EK, Suh I, Hope TA
• Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome.
  European urology focus 2020 Calais J, Armstrong WR, Kishan AU, Booker KM, Hope TA, Fendler WP, Elashoff D, Nickols NG, Czernin J
• From Compassionate Use to Phase 3 Trial: The Impact of Germany's PSMA-617 Literature.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Hope TA
• Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Hope TA
• Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer.
  Cancer medicine 2020 Borno HT, Kuo Lin T, Odisho AY, Desai A, Koshkin V, Werner K, Legaspi N, Bucknor M, Bell A, Zhang S, Hope TA
• Gallium-68 prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study.
  EJNMMI research 2020 Lawhn-Heath C, Yom SS, Liu C, Villanueva-Meyer JE, Aslam M, Smith R, Narwal M, Juarez R, Behr SC, Pampaloni MH, Chan JW, Glastonbury CM, Hope TA, Flavell RR
• Introduction to the D-SPECT for Technologists: Workflow Using a Dedicated Digital Cardiac Camera.
  Journal of nuclear medicine technology 2020 Johnson RD, Bath NK, Rinker J, Fong S, St James S, Pampaloni MH, Hope TA
• Disparities in PET Imaging for Prostate Cancer at a Tertiary Academic Medical Center.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Bucknor MD, Lichtensztajn DY, Lin TK, Borno HT, Gomez SL, Hope TA
• A Conversation Between Joseph Osborne and Thomas Hope.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Osborne JR, Hope TA
• NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer.
  International journal of radiation oncology, biology, physics 2020 Hall WA, Paulson E, Davis BJ, Spratt DE, Morgan TM, Dearnaley D, Tree AC, Efstathiou JA, Harisinghani M, Jani AB, Buyyounouski MK, Pisansky TM, Tran PT, Karnes RJ, Chen RC, Cury FL, Michalski JM, …
• 68Ga-PSMA-11 PET/MRI: determining ideal acquisition times to reduce noise and increase image quality.
  EJNMMI physics 2020 Murthy V, Smith RL, Tao DH, Lawhn-Heath CA, Korenchan DE, Larson PEZ, Flavell RR, Hope TA
• False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial.
  European journal of nuclear medicine and molecular imaging 2020 Fendler WP, Calais J, Eiber M, Simko JP, Kurhanewicz J, Santos RD, Feng FY, Reiter RE, Rettig MB, Nickols NG, Kishan AU, PSMA PET Reader Group, Slavik R, Carroll PR, Lawhn-Heath C, Herrmann K, Czernin…
• PET/Magnetic Resonance Imaging Applications in Abdomen and Pelvis.
  Magnetic resonance imaging clinics of North America 2020 Panda A, Goenka AH, Hope TA, Veit-Haibach P
• The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors.
  Pancreas 2020 Halfdanarson TR, Strosberg JR, Tang L, Bellizzi AM, Bergsland EK, O'Dorisio TM, Halperin DM, Fishbein L, Eads J, Hope TA, Singh S, Salem R, Metz DC, Naraev BG, Reidy-Lagunes DL, Howe JR, Pommier RF, …
• Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines.
  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 Singh S, Bergsland EK, Card CM, Hope TA, Kunz PL, Laidley DT, Lawrence B, Leyden S, Metz DC, Michael M, Modahl LE, Myrehaug S, Padda SK, Pommier RF, Ramirez RA, Soulen M, Strosberg J, Sung A, Thawer A…
• MR-based Attenuation Correction for Brain PET Using 3D Cycle-Consistent Adversarial Network.
  IEEE transactions on radiation and plasma medical sciences 2020 Gong K, Yang J, Larson PEZ, Behr SC, Hope TA, Seo Y, Li Q
• North American Neuroendocrine Tumor Society Guide for Neuroendocrine Tumor Patient Health Care Providers During COVID-19.
  Pancreas 2020 Bergsland EK, Halperin DM, Dillon JS, Dasari NA, Kunz PL, Soares HP, Pryma D, Bodei L, Hope T, Soulen MC, Mailman J, Howe JR
• Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Bodei L, Bergsland E, de Herder WW, Ferone D, Hicks RJ, Hope TA, Kunikowska J, Pavel M, Reidy-Lagunes D, Siveke J, Strosberg J, Dittmer U, Herrmann K
• Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Lawhn-Heath C, Fidelman N, Chee B, Jivan S, Armstrong E, Zhang L, Lindsay S, Bergsland EK, Hope TA
• Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Fendler WP, Ferdinandus J, Czernin J, Eiber M, Flavell RR, Behr SC, Wu IK, Lawhn-Heath C, Pampaloni MH, Reiter RE, Rettig MB, Gartmann J, Murthy V, Slavik R, Carroll PR, Herrmann K, Calais J, Hope TA
• Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET-Positive Osseous Lesions in Prostate Cancer.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Chiu LW, Lawhn-Heath C, Behr SC, Juarez R, Perez PM, Lobach I, Bucknor MD, Hope TA, Flavell RR
• A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors.
  Journal of surgical oncology 2020 Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK
• A Conversation with John Sunderland, Johannes Czernin, and Thomas Hope.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Sunderland JJ, Czernin J, Hope T
• Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Jadvar H, Ballas LK, Choyke PL, Fanti S, Gulley JL, Herrmann K, Hope TA, Klitzke AK, Oldan JD, Pomper MG, Rowe SP, Subramaniam RM, Taneja SS, Vargas HA, Ahuja S
• Bone material analogues for PET/MRI phantoms.
  Medical physics 2020 Chandramohan D, Cao P, Han M, An H, Sunderland JJ, Kinahan PE, Laforest R, Hope TA, Larson PEZ
• NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Hope TA, Bodei L, Chan JA, El-Haddad G, Fidelman N, Kunz PL, Mailman J, Menda Y, Metz DC, Mittra ES, Pryma DA, Reidy-Lagunes DL, Singh S, Strosberg JR
• Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A,…
• The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.
  Pancreas 2020 Howe JR, Merchant NB, Conrad C, Keutgen XM, Hallet J, Drebin JA, Minter RM, Lairmore TC, Tseng JF, Zeh HJ, Libutti SK, Singh G, Lee JE, Hope TA, Kim MK, Menda Y, Halfdanarson TR, Chan JA, Pommier RF
• Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.
  Journal of surgical oncology 2019 Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK
• Complete Response and Immune-Mediated Adverse Effects With Checkpoint Blockade: Treatment of Mismatch Repair-Deficient Colorectal Neuroendocrine Carcinoma.
  JCO precision oncology 2019 Whitman J, Kardosh A, Diaz L, Fong L, Hope T, Onodera C, Joseph N, Le D, Fisher G, Bergsland E
• Mucinous rectal cancer: concepts and imaging challenges.
  Abdominal radiology (New York) 2019 Horvat N, Hope TA, Pickhardt PJ, Petkovska I
• Rectal cancer lexicon: consensus statement from the society of abdominal radiology rectal & anal cancer disease-focused panel.
  Abdominal radiology (New York) 2019 Hope TA, Gollub MJ, Arya S, Bates DDB, Ganeshan D, Harisinghani M, Jhaveri KS, Kassam Z, Kim DH, Korngold E, Lalwani N, Moreno CC, Nougaret S, Paroder V, Paspulati RM, Golia Pernicka JS, Petkovska I, …
• The use of PET/MRI for imaging rectal cancer.
  Abdominal radiology (New York) 2019 Hope TA, Kassam Z, Loening A, McNamara MM, Paspulati R
• What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' reply.
  The Lancet. Oncology 2019 Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Fendler WP, Czernin J
• Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors.
  Journal of surgical oncology 2019 Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK
• A multi-disciplinary model of survivorship care following definitive chemoradiation for anal cancer.
  BMC cancer 2019 Savoie MB, Laffan A, Brickman C, Daniels B, Levin A, Rowen T, Smith J, Van Blarigan EL, Hope TA, Berry-Lawhorn JM, Anwar M, Van Loon K
• Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Fendler WP, Weber M, Iravani A, Hofman MS, Calais J, Czernin J, Ilhan H, Saad F, Small EJ, Smith MR, Perez PM, Hope TA, Rauscher I, Londhe A, Lopez-Gitlitz A, Cheng S, Maurer T, Herrmann K, Eiber M, …
• EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).
  European journal of nuclear medicine and molecular imaging 2019 Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, …
• Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.
  Molecular pharmaceutics 2019 Wang S, Blaha C, Santos R, Huynh T, Hayes TR, Beckford-Vera DR, Blecha JE, Hong AS, Fogarty M, Hope TA, Raleigh DR, Wilson DM, Evans MJ, VanBrocklin HF, Ozawa T, Flavell RR
• Correlation of DOTATOC Uptake and Pathologic Grade in Neuroendocrine Tumors.
  Pancreas 2019 Chan H, Moseley C, Zhang L, Bergsland EK, Pampaloni MH, Van Loon K, Hope TA
• Hormone receptor expression of colorectal cancer diagnosed during the peri-partum period.
  Endocrine connections 2019 Silverstein J, Kidder W, Fisher S, Hope TA, Maisel S, Ng D, Van Ziffle J, Atreya CE, Van Loon K
• 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.
  The Lancet. Oncology 2019 Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig …
• Can the Injected Dose Be Reduced in 68Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2019 Rauscher I, Fendler WP, Hope TA, Quon A, Nekolla SG, Calais J, Richter A, Haller B, Herrmann K, Weber WA, Czernin J, Eiber M
• Author Reply.
  Urology 2019 Boreta L, Gadzinski AJ, Hope TA, Feng FY
• NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2019 Hope TA, Abbott A, Colucci K, Bushnell DL, Gardner L, Graham WS, Lindsay S, Metz DC, Pryma DA, Stabin MG, Strosberg JR
• Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.
  JAMA oncology 2019 Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J, Smith R,…
• Summary of the First ISMRM-SNMMI Workshop on PET/MRI: Applications and Limitations.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2019 Hope TA, Fayad ZA, Fowler KJ, Holley D, Iagaru A, McMillan AB, Veit-Haiback P, Witte RJ, Zaharchuk G, Catana C
• Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer.
  AJR. American journal of roentgenology 2019 Lawhn-Heath C, Flavell RR, Behr SC, Yohannan T, Greene KL, Feng F, Carroll PR, Hope TA
• Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy.
  Urology 2019 Boreta L, Gadzinski AJ, Wu SY, Xu M, Greene K, Quanstrom K, Nguyen HG, Carroll PR, Hope TA, Feng FY
• Spatial gradients of healthy aging: a study of myelin-sensitive maps.
  Neurobiology of aging 2019 Karolis VR, Callaghan MF, Tseng CJ, Hope T, Weiskopf N, Rees G, Cappelletti M
• 111In-Pentetreotide Scintigraphy Versus 68Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2019 Hope TA, Calais J, Zhang L, Dieckmann W, Millo C
• Proceedings: Pathways for Successful Translation of New Imaging Agents and Modalities-Phase III Studies.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2019 Gambhir SS, Shankar LK, Rosenthal E, Warram JM, Ghesani M, Hope TA, Jacobs PM, Jacobson GB, Wilson T, Siegel BA
• AUTHOR REPLY.
  Urology 2019 Wu SY, Feng FY, Hope TA
• Ectopic Thyroid-Stimulating Hormone-Secreting Pituitary Adenoma of the Nasopharynx Diagnosed by Gallium 68 DOTATATE Positron Emission Tomography/Computed Tomography.
  World neurosurgery 2019 Kim S, Dillon WP, Hope TA, El-Sayed IH, van Zante A, Wu K, Masharani U
• Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer.
  European urology oncology 2019 Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M, Hope TA, Carroll PR, Feng FY
• Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases.
  Clinical nuclear medicine 2019 Perez PM, Hope TA, Behr SC, van Zante A, Small EJ, Flavell RR
• Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer.
  Urology 2018 Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA
• WITHDRAWN: PSMA-PET: a maturing tool.
  Urology 2018 Wu SY, Feng FY, Hope TA
• Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2018 Hope TA, Goodman JZ, Allen IE, Calais J, Fendler WP, Carroll PR
• Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2018 Behr SC, Aggarwal R, VanBrocklin HF, Flavell RR, Gao K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, Carroll PR, Nguyen HG, …
• Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting.
  The Prostate 2018 Miyahira AK, Den RB, Carlo MI, de Leeuw R, Hope TA, Karzai F, McKay RR, Salami SS, Simons JW, Pienta KJ, Soule HR
• Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer.
  Radiology 2018 Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA
• Developing an efficient phase-matched attenuation correction method for quiescent period PET in abdominal PET/MRI.
  Physics in medicine and biology 2018 Yang J, Liu J, Wiesinger F, Menini A, Zhu X, Hope TA, Seo Y, Larson PEZ
• Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by 68Ga-PSMA-11 PET/CT.
  Clinical genitourinary cancer 2018 Polverari G, Ceci F, Allen-Auerbach M, Gupta P, Fishbein MC, Reiter RE, Lee JM, Hope TA, Carroll RM, Czernin J, Calais J
• Does Extended PET Acquisition in PET/MRI Rectal Cancer Staging Improve Results?
  AJR. American journal of roentgenology 2018 Bailey JJ, Jordan EJ, Burke C, Ohliger MA, Wang ZJ, Van Loon K, Varma MG, Hope TA
• PET/MR Imaging of the Pancreas.
  Magnetic resonance imaging clinics of North America 2018 Mallak N, Hope TA, Guimaraes AR
• Prostate cancer PET tracers: essentials for the urologist.
  The Canadian journal of urology 2018 Fraum TJ, Ludwig DR, Kim EH, Schroeder P, Hope TA, Ippolito JE
• Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer.
  European journal of nuclear medicine and molecular imaging 2018 Afshar-Oromieh A, Debus N, Uhrig M, Hope TA, Evans MJ, Holland-Letz T, Giesel FL, Kopka K, Hadaschik B, Kratochwil C, Haberkorn U
• PET/MRI for Gastrointestinal Imaging: Current Clinical Status and Future Prospects.
  Gastroenterology clinics of North America 2018 Fraum TJ, Ludwig DR, Hope TA, Fowler KJ
• Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma.
  Abdominal radiology (New York) 2018 Lee JY, Huo EJ, Weinstein S, Santos C, Monto A, Corvera CU, Yee J, Hope TA
• Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications.
  AJR. American journal of roentgenology 2018 Hope TA, Afshar-Oromieh A, Eiber M, Emmett L, Fendler WP, Lawhn-Heath C, Rowe SP
• Clinical Evaluation of 68Ga-PSMA-II and 68Ga-RM2 PET Images Reconstructed With an Improved Scatter Correction Algorithm.
  AJR. American journal of roentgenology 2018 Wangerin KA, Baratto L, Khalighi MM, Hope TA, Gulaka PK, Deller TW, Iagaru AH
• Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.
  European urology oncology 2018 Aggarwal R, Wei X, Kim W, Small EJ, Ryan CJ, Carroll P, Cooperberg M, Evans MJ, Hope T
• Ferumoxytol-enhanced MRI in the peripheral vasculature.
  Clinical radiology 2018 Lehrman ED, Plotnik AN, Hope T, Saloner D
• Variable refocusing flip angle single-shot fast spin echo imaging of liver lesions: increased speed and lesion contrast.
  Abdominal radiology (New York) 2018 Hicks RM, Loening AM, Ohliger MA, Vasanawala SS, Hope TA
• Zero TE-based pseudo-CT image conversion in the head and its application in PET/MR attenuation correction and MR-guided radiation therapy planning.
  Magnetic resonance in medicine 2018 Wiesinger F, Bylund M, Yang J, Kaushik S, Shanbhag D, Ahn S, Jonsson JH, Lundman JA, Hope T, Nyholm T, Larson P, Cozzini C
• Correction to: LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound.
  Abdominal radiology (New York) 2018 Kambadakone AR, Fung A, Gupta RT, Hope TA, Fowler KJ, Lyshchik A, Ganesan K, Yaghmai V, Guimaraes AR, Sahani DV, Miller FH
• LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma.
  Abdominal radiology (New York) 2018 Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR
• LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound.
  Abdominal radiology (New York) 2018 Kambadakone AR, Fung A, Gupta RT, Hope TA, Fowler KJ, Lyshchik A, Ganesan K, Yaghmai V, Guimaraes AR, Sahani DV, Miller FH
• Letter to the editor response.
  Abdominal radiology (New York) 2018 Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR, Sirlin CB, Tang A, Kielar A
• Scatter Artifact with Ga-68-PSMA-11 PET: Severity Reduced With Furosemide Diuresis and Improved Scatter Correction.
  Molecular imaging 2018 Lawhn-Heath C, Flavell RR, Korenchan DE, Deller T, Lake S, Carroll PR, Hope TA
• Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017 Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M, Hope T, Reiter R, Maurer T, Weber WA, Fendler WP
• Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017 Leynes AP, Yang J, Wiesinger F, Kaushik SS, Shanbhag DD, Seo Y, Hope TA, Larson PEZ
• Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017 Hope TA, Bergsland EK, Bozkurt MF, Graham M, Heaney AP, Herrmann K, Howe JR, Kulke MH, Kunz PL, Mailman J, May L, Metz DC, Millo C, O'Dorisio S, Reidy-Lagunes DL, Soulen MC, Strosberg JR
• Motion robust high resolution 3D free-breathing pulmonary MRI using dynamic 3D image self-navigator.
  Magnetic resonance in medicine 2017 Jiang W, Ong F, Johnson KM, Nagle SK, Hope TA, Lustig M, Larson PEZ
• Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer.
  EJNMMI research 2017 Lake ST, Greene KL, Westphalen AC, Behr SC, Zagoria R, Small EJ, Carroll PR, Hope TA
• The Role of PET/MR Imaging in Precision Medicine.
  PET clinics 2017 Huo E, Wilson DM, Eisenmenger L, Hope TA
• 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.
  European journal of nuclear medicine and molecular imaging 2017 Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, Giesel F, Haberkorn U, Hope TA, Kopka K, Krause BJ, Mottaghy FM, Schöder H, Sunderland J, Wan S, Wester HJ, Fanti S, Herrmann K
• PET/MR Imaging in Gynecologic Oncology.
  Magnetic resonance imaging clinics of North America 2017 Ohliger MA, Hope TA, Chapman JS, Chen LM, Behr SC, Poder L
• Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017 Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg MR, Feng F, Chang A, Ryan CJ, Small EJ, Carroll PR
• Evaluation of Sinus/Edge-Corrected Zero-Echo-Time-Based Attenuation Correction in Brain PET/MRI.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017 Yang J, Wiesinger F, Kaushik S, Shanbhag D, Hope TA, Larson PEZ, Seo Y
• Change in Liver Imaging Reporting and Data System Characterization of Focal Liver Lesions Using Gadoxetate Disodium Magnetic Resonance Imaging Compared With Contrast-Enhanced Computed Tomography.
  Journal of computer assisted tomography 2017 Hope TA, Aslam R, Weinstein S, Yeh BM, Corvera CU, Monto A, Yee J
• 68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017 Fendler WP, Calais J, Allen-Auerbach M, Bluemel C, Eberhardt N, Emmett L, Gupta P, Hartenbach M, Hope TA, Okamoto S, Pfob CH, Pöppel TD, Rischpler C, Schwarzenböck S, Stebner V, Unterrainer M, Zacho …
• Technical Note: Fast respiratory motion estimation using sorted singles without unlist processing: A feasibility study.
  Medical physics 2017 Yang J, Khalighi M, Hope TA, Ordovas K, Seo Y
• Incidental Detection of Head and Neck Squamous Cell Carcinoma on 68Ga-PSMA-11 PET/CT.
  Clinical nuclear medicine 2017 Lawhn-Heath C, Flavell RR, Glastonbury C, Hope TA, Behr SC
• PET/MRI: Where might it replace PET/CT?
  Journal of magnetic resonance imaging : JMRI 2017 Ehman EC, Johnson GB, Villanueva-Meyer JE, Cha S, Leynes AP, Larson PEZ, Hope TA
• Hybrid ZTE/Dixon MR-based attenuation correction for quantitative uptake estimation of pelvic lesions in PET/MRI.
  Medical physics 2017 Leynes AP, Yang J, Shanbhag DD, Kaushik SS, Seo Y, Hope TA, Wiesinger F, Larson PE
• Multiple arterial phase MRI of arterial hypervascular hepatic lesions: improved arterial phase capture and lesion enhancement.
  Abdominal radiology (New York) 2017 Ikram NS, Yee J, Weinstein S, Yeh BM, Corvera CU, Monto A, Hope TA
• Quantitative Evaluation of Atlas-based Attenuation Correction for Brain PET in an Integrated Time-of-Flight PET/MR Imaging System.
  Radiology 2017 Yang J, Jian Y, Jenkins N, Behr SC, Hope TA, Larson PEZ, Vigneron D, Seo Y
• 18F Fluorocholine PET/MR Imaging in Patients with Primary Hyperparathyroidism and Inconclusive Conventional Imaging: A Prospective Pilot Study.
  Radiology 2017 Kluijfhout WP, Pasternak JD, Gosnell JE, Shen WT, Duh QY, Vriens MR, de Keizer B, Hope TA, Glastonbury CM, Pampaloni MH, Suh I
• Diagnostic performance of computed tomography for parathyroid adenoma localization; a systematic review and meta-analysis.
  European journal of radiology 2017 Kluijfhout WP, Pasternak JD, Beninato T, Drake FT, Gosnell JE, Shen WT, Duh QY, Allen IE, Vriens MR, de Keizer B, Hope TA, Suh I
• Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy.
  Abdominal radiology (New York) 2016 Ehman EC, Umetsu SE, Ohliger MA, Fidelman N, Ferrell LD, Yeh BM, Yee J, Hope TA
• SNMMI Comment on the 2016 Society of Surgical Oncology "Choosing Wisely" Recommendation on the Use of PET/CT in Colorectal Cancer.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2016 Zukotynski K, Jadvar H, Hope T, Subramaniam RM, Van Loon K, Varma M, Niederkohr RD, PET Center of Excellence
• 68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2016 Hope TA, Truillet C, Ehman EC, Afshar-Oromieh A, Aggarwal R, Ryan CJ, Carroll PR, Small EJ, Evans MJ
• Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent.
  Abdominal radiology (New York) 2016 Kim SY, Wu EH, Park SH, Wang ZJ, Hope TA, Yee J, Zhao LQ, Chang WC, Yeh BM
• Targeted PET imaging for prostate-specific membrane antigen in prostate cancer.
  Future oncology (London, England) 2016 Hope TA, Aggarwal RR, Westphalen AC, Cooperberg MR, Greene KL
• Performance of magnetic resonance imaging in the evaluation of first-time and reoperative primary hyperparathyroidism.
  Surgery 2016 Kluijfhout WP, Venkatesh S, Beninato T, Vriens MR, Duh QY, Wilson DM, Hope TA, Suh I
• Radiation dosimetry of (68)Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing.
  European journal of nuclear medicine and molecular imaging 2016 Afshar-Oromieh A, Hetzheim H, Kübler W, Kratochwil C, Giesel FL, Hope TA, Eder M, Eisenhut M, Kopka K, Haberkorn U
• Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.
  Abdominal radiology (New York) 2016 Ehman EC, Behr SC, Umetsu SE, Fidelman N, Yeh BM, Ferrell LD, Hope TA
• Comparison of diffusion-weighted imaging and T2-weighted single shot fast spin-echo: Implications for LI-RADS characterization of hepatocellular carcinoma.
  Magnetic resonance imaging 2016 Hicks RM, Yee J, Ohliger MA, Weinstein S, Kao J, Ikram NS, Hope TA
• Transient washout of hepatic hemangiomas: Potential pitfall mimicking malignancy.
  Radiology case reports 2016 Becker-Weidman DJ, Hope TA, Doshi PH, Patel A, Mitchell DG
• Safety and technique of ferumoxytol administration for MRI.
  Magnetic resonance in medicine 2016 Vasanawala SS, Nguyen KL, Hope MD, Bridges MD, Hope TA, Reeder SB, Bashir MR
• Correcting for respiratory motion in liver PET/MRI: preliminary evaluation of the utility of bellows and navigated hepatobiliary phase imaging.
  EJNMMI physics 2015 Hope TA, Verdin EF, Bergsland EK, Ohliger MA, Corvera CU, Nakakura EK
• Combined parenchymal and vascular imaging: High spatiotemporal resolution arterial evaluation of hepatocellular carcinoma.
  Journal of magnetic resonance imaging : JMRI 2015 Hope TA, Petkovska I, Saranathan M, Hargreaves BA, Vasanawala SS
• Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor.
  Abdominal imaging 2015 Hope TA, Pampaloni MH, Nakakura E, VanBrocklin H, Slater J, Jivan S, Aparici CM, Yee J, Bergsland E
• Detection of Small Pulmonary Nodules with Ultrashort Echo Time Sequences in Oncology Patients by Using a PET/MR System.
  Radiology 2015 Burris NS, Johnson KM, Larson PE, Hope MD, Nagle SK, Behr SC, Hope TA
• Vascular Imaging With Ferumoxytol as a Contrast Agent.
  AJR. American journal of roentgenology 2015 Hope MD, Hope TA, Zhu C, Faraji F, Haraldsson H, Ordovas KG, Saloner D
• Somatostatin imaging of neuroendocrine-differentiated prostate cancer.
  Clinical nuclear medicine 2015 Hope TA, Aggarwal R, Simko JP, VanBrocklin HF, Ryan CJ
• Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses.
  AJR. American journal of roentgenology 2015 Kim SY, Park SH, Wu EH, Wang ZJ, Hope TA, Chang WC, Yeh BM
• Greater asymmetric wall shear stress in Sievers' type 1/LR compared with 0/LAT bicuspid aortic valves after valve-sparing aortic root replacement.
  The Journal of thoracic and cardiovascular surgery 2015 Stephens EH, Hope TA, Kari FA, Kvitting JP, Liang DH, Herfkens RJ, Miller DC
• Hepatobiliary agents and their role in LI-RADS.
  Abdominal imaging 2015 Hope TA, Fowler KJ, Sirlin CB, Costa EA, Yee J, Yeh BM, Heiken JP
• Neuroendocrine tumors: beyond the abdomen.
  Journal of computer assisted tomography 2014 Jacobs MA, Weinstein S, Hope TA, Aslam R, Yee J, Coakley F
• MR imaging of diffuse liver disease: from technique to diagnosis.
  Radiologic clinics of North America 2014 Hope TA, Ohliger MA, Qayyum A
• Functional and molecular imaging techniques in aortic aneurysm disease.
  Current opinion in cardiology 2013 Hope MD, Hope TA
• Evaluation of Marfan patients status post valve-sparing aortic root replacement with 4D flow.
  Magnetic resonance imaging 2013 Hope TA, Kvitting JP, Hope MD, Miller DC, Markl M, Herfkens RJ
• Improvement of gadoxetate arterial phase capture with a high spatio-temporal resolution multiphase three-dimensional SPGR-Dixon sequence.
  Journal of magnetic resonance imaging : JMRI 2013 Hope TA, Saranathan M, Petkovska I, Hargreaves BA, Herfkens RJ, Vasanawala SS
• Intravenous vasopressin for the prevention of nontarget gastrointestinal embolization during liver-directed cancer treatment: experimental study in a porcine model.
  Journal of vascular and interventional radiology : JVIR 2012 Durack JC, Hope TA, Seo Y, Saeed M, He J, Wilson MW, Kerlan RK, Ring EJ
• Evaluation of imatinib mesylate as a possible treatment for nephrogenic systemic fibrosis in a rat model.
  Magnetic resonance imaging 2012 Hope TA, Leboit PE, High WA, Fu Y, Brasch RC
• Gadolinium accumulation and fibrosis in the liver after administration of gadoxetate disodium in a rat model of active hepatic fibrosis.
  Radiology 2012 Hope TA, Doherty A, Fu Y, Aslam R, Qayyum A, Brasch RC
• Improved risk assessment for abdominal aortic aneurysm rupture: off-the-wall imaging.
  Journal of the American College of Cardiology 2011 Hope TA, Hope MD
• 4D flow CMR in assessment of valve-related ascending aortic disease.
  JACC. Cardiovascular imaging 2011 Hope MD, Hope TA, Crook SE, Ordovas KG, Urbania TH, Alley MT, Higgins CB
• Impaired social recognition memory in recombination activating gene 1-deficient mice.
  Brain research 2011 McGowan PO, Hope TA, Meck WH, Kelsoe G, Williams CL
• Four-dimensional flow magnetic resonance imaging with wall shear stress analysis before and after repair of aortopulmonary fistula.
  Circulation. Cardiovascular imaging 2010 Hope MD, Hope TA, Urbania TH, Higgins CB
• Bicuspid aortic valve: four-dimensional MR evaluation of ascending aortic systolic flow patterns.
  Radiology 2010 Hope MD, Hope TA, Meadows AK, Ordovas KG, Urbania TH, Alley MT, Higgins CB
• Clinical evaluation of aortic coarctation with 4D flow MR imaging.
  Journal of magnetic resonance imaging : JMRI 2010 Hope MD, Meadows AK, Hope TA, Ordovas KG, Saloner D, Reddy GP, Alley MT, Higgins CB
• Nephrogenic systemic fibrosis in rats treated with erythropoietin and intravenous iron.
  Radiology 2009 Hope TA, High WA, Leboit PE, Chaopathomkul B, Rogut VS, Herfkens RJ, Brasch RC
• Hemodynamics in Normal Cerebral Arteries: Qualitative Comparison of 4D Phase-Contrast Magnetic Resonance and Image-Based Computational Fluid Dynamics.
  Journal of engineering mathematics 2009 Cebral JR, Putman CM, Alley MT, Hope T, Bammer R, Calamante F
• Evaluation of intracranial stenoses and aneurysms with accelerated 4D flow.
  Magnetic resonance imaging 2009 Hope TA, Hope MD, Purcell DD, von Morze C, Vigneron DB, Alley MT, Dillon WP
• Nephrogenic systemic fibrosis in patients with chronic kidney disease who received gadopentetate dimeglumine.
  Investigative radiology 2009 Hope TA, Herfkens RJ, Denianke KS, LeBoit PE, Hung YY, Weil E
• Initial experience characterizing a type I endoleak from velocity profiles using time-resolved three-dimensional phase-contrast MRI.
  Journal of vascular surgery 2009 Hope TA, Zarins CK, Herfkens RJ
• Complete intracranial arterial and venous blood flow evaluation with 4D flow MR imaging.
  AJNR. American journal of neuroradiology 2008 Hope MD, Purcell DD, Hope TA, von Morze C, Vigneron DB, Alley MT, Dillon WP
• Images in cardiovascular medicine. Evaluation of bicuspid aortic valve and aortic coarctation with 4D flow magnetic resonance imaging.
  Circulation 2008 Hope MD, Meadows AK, Hope TA, Ordovas KG, Reddy GP, Alley MT, Higgins CB
• Imaging of the thoracic aorta with time-resolved three-dimensional phase-contrast MRI: a review.
  Seminars in thoracic and cardiovascular surgery 2008 Hope TA, Herfkens RJ
• Comparison of flow patterns in ascending aortic aneurysms and volunteers using four-dimensional magnetic resonance velocity mapping.
  Journal of magnetic resonance imaging : JMRI 2007 Hope TA, Markl M, Wigström L, Alley MT, Miller DC, Herfkens RJ
• Time-resolved 3D quantitative flow MRI of the major intracranial vessels: initial experience and comparative evaluation at 1.5T and 3.0T in combination with parallel imaging.
  Magnetic resonance in medicine 2007 Bammer R, Hope TA, Aksoy M, Alley MT